Journal article
Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine
The Journal of adolescent health : official publication of the Society for Adolescent Medicine, Vol.39(2), pp.296-301
08/2006
DOI: 10.1016/j.jadohealth.2006.03.011
PMID: 16857545
Abstract
The purpose of this Position Paper is to review the published Black Box Warning regarding depot medroxyprogesterone acetate (DMPA) and bone loss as it relates to adolescent girls. The scientific findings that prompted the Food and Drug Administration to issue the warning are reviewed and the following additional issues are considered: (1) likely low risk of fracture related to DMPA use, (2) evidence of at least partial recovery after discontinuation of the method, and (3) the need to balance the physical, social and economic cost of adolescent pregnancy versus the immediate and long-term impact of DMPA on bone. A list of clinical guidelines is included, the main recommendation of which is to continue prescription of DMPA, with counseling about the risks and benefits, in most of the adolescent population desiring to use this contraceptive method.
Details
- Title: Subtitle
- Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine
- Creators
- Barbara A Cromer - CASE School of Medicine, Cleveland, Ohio, USADelia ScholesAbbey BerensonTim CundyM Kathleen Clark - University of Iowa, NursingAndrew M Kaunitz
- Resource Type
- Journal article
- Publication Details
- The Journal of adolescent health : official publication of the Society for Adolescent Medicine, Vol.39(2), pp.296-301
- DOI
- 10.1016/j.jadohealth.2006.03.011
- PMID
- 16857545
- NLM abbreviation
- J Adolesc Health
- eISSN
- 1879-1972
- Publisher
- United States
- Language
- English
- Date published
- 08/2006
- Academic Unit
- Nursing
- Record Identifier
- 9983557482502771
Metrics
51 Record Views